Perspective Therapeutics Financial Overview
Perspective Therapeutics's market cap is currently $214.09M. The company's EPS TTM is $-0.35; its P/E ratio is -1.97; Perspective Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
